The history of the stem cell field offers pointers for future research on cancer stem cells.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
Oncology and Therapy Open Access 18 August 2022
-
Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma
Communications Biology Open Access 26 July 2021
-
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
BMC Cancer Open Access 05 September 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Quintana, E. et al. Nature 456, 593–598 (2008).
Dick, J.E. Blood 112, 4793–4807 (2008).
Dalerba, P., Cho, R.W. & Clarke, M.F. Annu. Rev. Med. 58, 267–284 (2007).
Kennedy, J.A. et al. Science 318, 1722; author reply 1722 (2007).
Vaillant, F. et al. Cancer Res. 68, 7711–7717 (2008).
Kelly, P.N. et al. Science 317, 337 (2007).
Barker, N. et al. Nature advance online publication, doi:10.1038/nature07602 (17 December 2008).
Zhu, L. et al. Nature advance online publication, doi:10.1038/nature07589 (17 December 2008).
Li, X. et al. J. Natl. Cancer Inst. 100, 672–679 (2008).
Furth, J. & Kahn, M. Amer. J. Cancer 31, 276–282 (1937).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dick, J. Looking ahead in cancer stem cell research. Nat Biotechnol 27, 44–46 (2009). https://doi.org/10.1038/nbt0109-44
Issue Date:
DOI: https://doi.org/10.1038/nbt0109-44
This article is cited by
-
Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
Oncology and Therapy (2022)
-
Blocking the GITR-GITRL pathway to overcome resistance to therapy in sarcomatoid malignant pleural mesothelioma
Communications Biology (2021)
-
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
BMC Cancer (2020)
-
Biglycan promotes the chemotherapy resistance of colon cancer by activating NF-κB signal transduction
Molecular and Cellular Biochemistry (2018)
-
Rictor has a pivotal role in maintaining quiescence as well as stemness of leukemia stem cells in MLL-driven leukemia
Leukemia (2017)